from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0634c/-

LFCtreatmentdescriptionclass of inhibitor

-0.588

Amikacinug/mL Amikacintranslation

-0.927

Cap5-10ug/mL Capreomycintranslation

-1.429

Rox10-50 ug/mL Roxithromycintranslation

-0.424

SM2-5 ug/mL Streptomycintranslation

-1.459

Tet5-10 ug/mL Tetracyclinetranslation

-0.280

Rif0.2-5ug/mL Rifampicintranscription

1.242

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.181

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.921

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.084

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.568

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.543

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.087

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.266

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.204

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.380

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.568

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.222

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.920

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.615

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.910

KCN5-20 ug/mL Potassium cyaniderespiration

-0.599

NaN30.2-2 mM Sodium aziderespiration

-0.443

Nigericin50 uM Nigericinrespiration

0.286

TRC10-150 ug/mL Triclosanrespiration

0.605

TRZ10-25 ug/mL Thioridazinerespiration

-0.065

Valinomycin0.5-10 uM Valinomycinrespiration

-1.938

ZnSO42 mM ZnSO4respiration

-0.057

menadione6-10 ug/mL Menadionerespiration

-0.281

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.410

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.025

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.902

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.248

NRP_1Non-replicating persistence stage 1dosRassociated

0.043

Amp0.2mg/mL AmpicillincellWall

-0.681

Cephalexin20-100 ug/mL CephalexincellWall

-0.328

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.167

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.675

EMB10-20 ug/mL EthambutolcellWall

-0.937

Eta12-40 ug/mL EthionamidecellWall

-1.088

INH0.2-0.4 ug/mL IsoniazidcellWall

0.026

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.551

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.838

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.225

BZA0.12 mg/mL BenzamidearomaticAmides

0.784

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.487

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.079

H2O24 mM hydrogen peroxideDNAdamaging

0.354

Levo10 ug/mL LevofloxacinDNAdamaging

0.448

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.708

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.084

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.735

UVUV-irradiationDNAdamaging

0.775

ARP41-4 ug/mL Antitubercular compound ARP4?

0.058

Antimycin12.5-50 ug/mL Antimycin A?

-0.356

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.227

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.104

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.195

PA8240.2-2 ug/mL PA-824?

-0.232

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.522

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.168

Verapamil50 uM Verapamil?

0.720

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.563

methoxatin10-20 ug/mL Methoxatin?